Literature DB >> 12524388

Inflammatory bowel disease in pregnancy.

E M Alstead1, C Nelson-Piercy.   

Abstract

Women and men with inflammatory bowel disease (IBD) frequently express concerns about fertility and pregnancy. The evidence suggests that women with IBD can expect to have a normal pregnancy outcome provided they have inactive disease. They have an increased risk of having a small or premature baby but the majority will have a normal outcome of pregnancy. The commonly used drugs appear to be safe and well tolerated in pregnancy. There remains a need for further studies in this area to help in the difficult decisions about the management of IBD around the time of conception and during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12524388      PMCID: PMC1774968          DOI: 10.1136/gut.52.2.159

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  [Pregnancy outcome in inflammatory bowel diseases].

Authors:  R Tennenbaum; P Marteau; E Elefant; J C Rambaud; R Modigliani; J P Gendre; J Cosnes
Journal:  Gastroenterol Clin Biol       Date:  1999-05

2.  Folic acid antagonists during pregnancy and the risk of birth defects.

Authors:  S Hernández-Díaz; M M Werler; A M Walker; A A Mitchell
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study.

Authors:  B Nørgård; K Fonager; H T Sørensen; J Olsen
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

4.  Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample.

Authors:  Kasper Ørding Olsen; Svend Juul; Ina Berndtsson; Tom Oresland; Søren Laurberg
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

5.  Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease.

Authors:  R O Rajapakse; B I Korelitz; J Zlatanic; P J Baiocco; G W Gleim
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

6.  Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study.

Authors:  Jason A Dominitz; Josephine C C Young; Edward J Boyko
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

7.  Azathioprine treatment and male fertility in inflammatory bowel disease.

Authors:  C Dejaco; C Mittermaier; W Reinisch; C Gasche; T Waldhoer; H Strohmer; G Moser
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

8.  Successful treatment of an acute flare of steroid-resistant Crohn's colitis during pregnancy with unfractionated heparin.

Authors:  Devang N Prajapati; Julianne R Newcomer; Jeanne Emmons; Majed Abu-Hajir; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2002-05       Impact factor: 5.325

9.  Population-based case control study of the safety of sulfasalazine use during pregnancy.

Authors:  B Nørgård; A E Czeizel; M Rockenbauer; J Olsen; H T Sørensen
Journal:  Aliment Pharmacol Ther       Date:  2001-04       Impact factor: 8.171

10.  Reversible male infertility due to sulphasalazine: studies in man and rat.

Authors:  C O'Moráin; P Smethurst; C J Doré; A J Levi
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

View more
  8 in total

1.  Caution with the use of cyclosporin in pregnancy.

Authors:  R Dor; C Blanshard
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

Review 2.  Recent advances in coeliac disease.

Authors:  D A van Heel; J West
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

Review 3.  Behçet's syndrome in pregnancy.

Authors:  Marcus Martineau; Dorian O Haskard; Catherine Nelson-Piercy
Journal:  Obstet Med       Date:  2010-03-04

Review 4.  IBD: reproductive health, pregnancy and lactation.

Authors:  Philip Hendy; Georgina Chadwick; Ailsa Hart
Journal:  Frontline Gastroenterol       Date:  2014-04-15

Review 5.  Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?

Authors:  A A van Bodegraven; Chris J J Mulder
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 6.  Management of inflammatory bowel disease in the pregnant patient.

Authors:  Flavio M Habal; Nikila C Ravindran
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

7.  Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma.

Authors:  Seon-Hyeong Lee; Joon Hee Kang; Ji Sun Ha; Jae-Seon Lee; Su-Jin Oh; Hyun-Jung Choi; Jaewhan Song; Soo-Youl Kim
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

8.  Living with Crohn's disease: an exploratory cross-sectional qualitative study into decision-making and expectations in relation to autologous haematopoietic stem cell treatment (the DECIDES study).

Authors:  Joanne Cooper; Iszara Blake; James O Lindsay; Christopher J Hawkey
Journal:  BMJ Open       Date:  2017-09-11       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.